Royal Bank of Canada’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-74,700
| Closed | -$7.42M | – | 7436 |
|
|
2019
Q3 | $7.42M | Sell |
74,700
-2,800
| -4% | -$266K | ﹤0.01% | 1789 |
|
|
2019
Q2 | $7.16M | Sell |
77,500
-342,800
| -82% | -$32.6M | ﹤0.01% | 1808 |
|
|
2019
Q1 | $39.7M | Buy |
420,300
+190,700
| +83% | +$16.7M | 0.02% | 664 |
|
|
2018
Q4 | $14.7M | Sell |
229,600
-385,900
| -63% | -$28.5M | 0.01% | 1187 |
|
|
2018
Q3 | $55.1M | Buy |
615,500
+108,400
| +21% | +$9.58M | 0.02% | 554 |
|
|
2018
Q2 | $40.3M | Buy |
507,100
+192,000
| +61% | +$15.9M | 0.02% | 661 |
|
|
2018
Q1 | $28.1M | Buy |
315,100
+225,800
| +253% | +$21.7M | 0.01% | 876 |
|
|
2017
Q4 | $9.32M | Buy |
89,300
+100
| +0.1% | +$11.3K | ﹤0.01% | 1661 |
|
|
2017
Q3 | $13M | Hold |
89,200
| – | – | 0.01% | 1362 |
|
|
2017
Q2 | $11.6M | Sell |
89,200
-20,000
| -18% | -$2.45M | 0.01% | 1419 |
|
|
2017
Q1 | $13.6M | Sell |
109,200
-71,300
| -40% | -$8.53M | 0.01% | 1293 |
|
|
2016
Q4 | $20.9M | Sell |
180,500
-25,400
| -12% | -$2.83M | 0.01% | 1037 |
|
|
2016
Q3 | $21.5M | Sell |
205,900
-388,300
| -65% | -$42M | 0.01% | 969 |
|
|
2016
Q2 | $58.6M | Buy |
594,200
+502,300
| +547% | +$52M | 0.03% | 408 |
|
|
2016
Q1 | $9.2M | Sell |
91,900
-130,200
| -59% | -$13.4M | 0.01% | 1431 |
|
|
2015
Q4 | $26.6M | Sell |
222,100
-134,500
| -38% | -$15.6M | 0.02% | 771 |
|
|
2015
Q3 | $38.6M | Buy |
356,600
+57,900
| +19% | +$7.19M | 0.03% | 452 |
|
|
2015
Q2 | $34.6M | Buy |
298,700
+33,700
| +13% | +$3.85M | 0.02% | 540 |
|
|
2015
Q1 | $30.5M | Buy |
265,000
+245,400
| +1,252% | +$29.3M | 0.02% | 600 |
|
|
2014
Q4 | $2.19M | Buy |
19,600
+9,600
| +96% | +$1.01M | ﹤0.01% | 2262 |
|
|
2014
Q3 | $948K | Buy |
+10,000
| New | +$902K | ﹤0.01% | 2890 |
|
|
2014
Q1 | – | Sell |
-394,800
| Closed | -$33.4M | – | 6493 |
|
|
2013
Q4 | $33.4M | Sell |
394,800
-56,400
| -13% | -$4.46M | 0.02% | 522 |
|
|
2013
Q3 | $34.8M | Buy |
451,200
+41,400
| +10% | +$2.9M | 0.03% | 467 |
|
|
2013
Q2 | $24M | Buy |
+409,800
| New | +$24.7M | 0.02% | 581 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Royal Bank of Canada's CELG Position: Q4 2019 in Review
Royal Bank of Canada sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 915,127 shares — an estimated $90.9M sold.
Royal Bank of Canada first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $396M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Royal Bank of Canada reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Royal Bank of Canada sold 915,127 Celgene Corp shares in Q4 2019, an estimated $90.9M.
- Royal Bank of Canada first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Royal Bank of Canada's Celgene Corp position peaked at $396M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.